bpc 157. The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC-157: The Secret Weapon for
Description
DISCLAIMER For Research Purposes Only
coagulans being the most studied
This drawback can be due to only one side of the NO-system employed in the studies (i.e., decreased function by L-NAME application) while the other part remained unchecked (i.e., over-increased function by L-arginine, and vice versa) [124,125]
The FDAs concern is twofold: Safety: Some substances are linked to toxicity, cardiac complications, or other serious adverse events
